GlassScriptPhysician profile
Katherine Phan Yee
NPI 1982970786
$1,094.04
in general payments reported to CMS, 2019-2025
8 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.00 · 2023: $124 · 2024: $723 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $448.55 | 2024-2025 | Invega Sustenna, Invega Trinza |
| Gilead Sciences, INC. | $315.38 | 2024-2025 | Epclusa |
| Braeburn INC. | $124.11 | 2023 | Brixadi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $121.36 | 2024 | Xifaxan |
| Viiv Healthcare Company | $28.02 | 2024 | Apretude |
| Otsuka America Pharmaceutical, INC. | $24.15 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $17.47 | 2025 | |
| Sunovion Pharmaceuticals INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Phan Yee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.